BARER SOL J
Insider CIK 1247015 · RESX Chairman of the Board, Director, 10% owner · MDGN Director · FOLD Director · AEGR Director · NSPR.OB Director · EDGE Director · CFRX Director · CERC Director · NEXI Director · TEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-06-05 | 2026-06-08 | 21,739 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-06-05 | 2026-06-08 | 21,739 | — | $0 | 448,011 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-05-28 | 2026-06-01 | 10,863 | — | $0 | 10,863 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-06-06 | 2025-06-09 | 17,158 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-06-06 | 2025-06-09 | 17,158 | — | $0 | 426,272 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-06-05 | 2025-06-09 | 21,739 | — | $0 | 21,739 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-06-15 | 2024-06-17 | 37,598 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-06-15 | 2024-06-17 | 37,598 | — | $0 | 409,114 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-06-06 | 2024-06-10 | 17,158 | — | $0 | 17,158 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-08-04 | 2023-08-07 | 28,162 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-08-04 | 2023-08-07 | 28,162 | — | $0 | 371,516 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-07-05 | 2023-07-07 | 44,983 | — | $0 | 44,983 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-06-15 | 2023-06-20 | 37,598 | — | $0 | 37,598 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 19,113 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 61,678 | — | $0 | 61,678 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 61,678 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 19,113 | — | $0 | 19,113 | SEC↗ |
| NEXI NexImmune, Inc. | D To issuer deriv | 2023-04-04 | 2023-04-06 | 155,900 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 155,900 | — | $0 | 155,900 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2023-03-30 | 2023-03-31 | 400,000 | $0.41 | $164.0K | 2,217,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-11-17 | 2022-11-17 | 75,000 | $0.48 | $36.0K | 1,817,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-11-16 | 2022-11-17 | 125,000 | $0.48 | $60.0K | 1,742,814 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-08-04 | 2022-08-08 | 28,162 | — | $0 | 28,162 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-06-14 | 2022-06-16 | 25,791 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-06-14 | 2022-06-16 | 25,791 | — | $0 | 343,354 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 61,678 | — | $0 | 61,678 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-06-02 | 2022-06-02 | 20,720 | $2.22 | $46.0K | 1,617,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-06-01 | 2022-06-02 | 40,000 | $2.35 | $94.0K | 1,597,094 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-05-31 | 2022-06-02 | 39,280 | $2.19 | $86.0K | 1,557,094 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2022-05-17 | 2022-05-18 | 42,000 | $3.35 | $140.7K | 42,000 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-03-23 | 2022-03-24 | 10,000 | $2.67 | $26.7K | 1,517,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-03-22 | 2022-03-23 | 30,000 | $2.41 | $72.3K | 1,507,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-03-21 | 2022-03-22 | 30,000 | $2.14 | $64.2K | 1,477,814 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2022-03-18 | 2022-03-21 | 30,000 | $2.11 | $63.3K | 1,447,814 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise deriv | 2021-12-21 | 2021-12-22 | 50,000 | — | $0 | 155,900 | SEC↗ |
| NEXI NexImmune, Inc. | M Exercise | 2021-12-21 | 2021-12-22 | 50,000 | $5.17 | $258.5K | 1,417,814 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2021-06-15 | 2021-06-17 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-06-14 | 2021-06-16 | 25,791 | — | $0 | 25,791 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-09 | 2021-06-10 | 22,565 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-09 | 2021-06-10 | 22,565 | — | $0 | 317,563 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-05 | 2021-06-08 | 17,565 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-05 | 2021-06-08 | 17,565 | — | $0 | 294,998 | SEC↗ |
| CFRX CONTRAFECT Corp | A Award deriv | 2021-05-18 | 2021-05-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 894,036 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 164,408 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 82,204 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 217,570 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 0 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 800,182 | — | $0 | 0 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 82,204 | — | $0 | 1,140,648 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 894,036 | — | $0 | 894,036 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 800,182 | — | $0 | 1,367,814 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 164,408 | — | $0 | 1,058,444 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 337,365 | — | $0 | 1,478,013 | SEC↗ |
| NEXI NexImmune, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 60,000 | $17.00 | $1.02M | 1,538,013 | SEC↗ |
| NEXI NexImmune, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 217,570 | — | $0 | 346,577 | SEC↗ |
| NEXI NexImmune, Inc. | A Award deriv | 2021-02-11 | 2021-02-16 | 19,113 | — | $0 | 225,013 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-08-11 | 2020-08-13 | 23,133 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-08-11 | 2020-08-13 | 23,133 | — | $0 | 277,433 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-06-11 | 2020-06-15 | 31,388 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-06-11 | 2020-06-15 | 31,388 | — | $0 | 254,300 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-06-09 | 2020-06-11 | 22,565 | — | $0 | 22,565 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-02-14 | 2020-02-18 | 2,470 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-02-14 | 2020-02-18 | 2,470 | — | $0 | 222,912 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 15,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 200,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 200,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 100,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 80,000 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 74,912 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | D To issuer deriv | 2020-02-03 | 2020-02-05 | 15,000 | — | $0 | 0 | SEC↗ |
| CERC Cerecor Inc. | A Award deriv | 2020-02-03 | 2020-02-05 | 500,000 | — | $0 | 500,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | J Other | 2019-12-05 | 2019-12-09 | 2,551,020 | — | $0 | 4,098,752 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | S Sale | 2019-12-05 | 2019-12-09 | 4,098,752 | $0.13 | $532.8K | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | G Gift | 2019-12-05 | 2019-12-09 | 365,854 | — | $0 | 1,547,732 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | J Other | 2019-12-05 | 2019-12-09 | 2,551,020 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | G Gift | 2019-12-05 | 2019-12-09 | 153,846 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | G Gift | 2019-12-05 | 2019-12-09 | 365,854 | — | $0 | 0 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | G Gift | 2019-12-05 | 2019-12-09 | 153,846 | — | $0 | 1,181,878 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-06-11 | 2019-06-13 | 31,388 | — | $0 | 31,388 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | P Buy | 2019-06-04 | 2019-06-05 | 104,500 | $9.60 | $1.00M | 220,442 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | P Buy | 2019-06-03 | 2019-06-03 | 111,000 | $8.98 | $996.8K | 115,942 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 4,942 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise deriv | 2019-03-15 | 2019-03-18 | 20,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | M Exercise | 2019-03-15 | 2019-03-18 | 20,000 | — | $0 | 678,075 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 2,162 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2018-08-15 | 2018-08-17 | 2,551,020 | $0.96 | $2.45M | 2,551,020 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-08-14 | 2018-08-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2018-06-19 | 2018-06-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-06-14 | 2018-07-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2018-06-14 | 2018-06-18 | 100,000 | — | $0 | 100,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-06-05 | 2018-06-07 | 17,565 | — | $0 | 17,565 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy deriv | 2017-10-17 | 2017-10-18 | 74,912 | — | $0 | 74,912 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2017-10-17 | 2017-10-18 | 421,032 | $1.26 | $530.5K | 1,028,032 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy deriv | 2017-07-25 | 2017-07-26 | 20,000 | $0.01 | $200 | 20,000 | SEC↗ |
| CFRX CONTRAFECT Corp | P Buy | 2017-07-25 | 2017-07-26 | 40,000 | $1.24 | $49.6K | 815,933 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | X Exercise deriv | 2017-07-07 | 2017-07-10 | 12,530 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | X Exercise | 2017-07-07 | 2017-07-10 | 12,530 | $2.39 | $29.9K | 658,075 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | A Award deriv | 2017-06-22 | 2017-08-10 | 80,000 | — | $0 | 80,000 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2017-06-20 | 2017-06-21 | 30,000 | $10.15 | $304.5K | 30,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2017-04-28 | 2017-05-01 | 100,000 | $1.57 | $157.0K | 607,000 | SEC↗ |
| GNMX Aevi Genomic Medicine, Inc | P Buy | 2017-04-26 | 2017-04-27 | 100,000 | $1.54 | $154.0K | 507,000 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2016-12-07 | 2016-12-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 14,700 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 19,927 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 9,988 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 12,854 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 5,012 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer deriv | 2016-11-29 | 2016-11-30 | 18,000 | — | $0 | 0 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | D To issuer | 2016-11-29 | 2016-11-30 | 29,890 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2016-07-07 | 2016-07-11 | 3,333,300 | $33.00 | $110.00M | 3,333,300 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2016-07-07 | 2016-07-11 | 33,333 | $33.00 | $1.10M | 33,333 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2016-06-30 | 2016-07-05 | 122,282 | — | $0 | 122,282 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | A Award deriv | 2016-06-21 | 2016-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2016-06-09 | 2016-06-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2016-04-15 | 2016-04-19 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2016-03-21 | 2016-03-23 | 423,729 | $0.59 | $250.0K | 423,729 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2016-03-21 | 2016-03-23 | 847,458 | $0.59 | $500.0K | 1,141,690 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 4,162 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 9,161 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 10,000 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 8,500 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 1,250 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | D To issuer deriv | 2016-01-26 | 2016-01-28 | 12,500 | — | $0 | 0 | SEC↗ |
| NSPR InspireMD, Inc. | A Award | 2016-01-26 | 2016-01-28 | 1 | — | $0 | 294,232 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 144,086 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 114,285 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 480,000 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion deriv | 2015-10-06 | 2015-10-08 | 65,809 | — | $0 | 0 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 105,319 | — | $0 | 587,810 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 48,103 | — | $0 | 482,491 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | P Buy | 2015-10-06 | 2015-10-08 | 45,000 | $11.00 | $495.0K | 632,810 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | J Other | 2015-10-06 | 2015-10-08 | 12,735 | $6.17 | $78.6K | 645,545 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 83,536 | — | $0 | 434,388 | SEC↗ |
| EDGE Edge Therapeutics, Inc. | C Conversion | 2015-10-06 | 2015-10-08 | 350,852 | — | $0 | 350,852 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2015-10-06 | 2015-10-08 | 153,846 | $6.50 | $1000.0K | 153,846 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-09-30 | 2015-10-02 | 81,549 | — | $0 | 81,549 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-06-30 | 2015-07-02 | 49,662 | — | $0 | 49,662 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2015-06-26 | 2015-06-29 | 18,000 | — | $0 | 18,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-03-31 | 2015-04-06 | 43,889 | $0.32 | $14.0K | 43,889 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2015-03-20 | 2015-03-23 | 50,000 | $8.45 | $422.5K | 407,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2015-03-09 | 2015-03-11 | 2,500,000 | — | $0 | 2,500,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2015-03-09 | 2015-03-11 | 2,500,000 | — | $0 | 2,942,308 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2015-02-20 | 2015-02-23 | 50,000 | $7.55 | $377.5K | 357,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2015-02-19 | 2015-02-23 | 100,000 | $7.38 | $738.0K | 307,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2015-02-18 | 2015-02-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2015-01-26 | 2015-02-02 | 91,601 | — | $0 | 91,601 | SEC↗ |
| NSPR InspireMD, Inc. | J Other deriv | 2015-01-05 | 2015-01-07 | 41,611 | — | $0 | 41,611 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2014-12-01 | 2014-12-02 | 365,854 | $4.10 | $1.50M | 365,854 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy deriv | 2014-11-07 | 2014-11-10 | 96,154 | — | $0 | 96,154 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2014-11-07 | 2014-11-10 | 192,308 | — | $0 | 442,308 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-07-24 | 2014-07-29 | 123,287 | — | $0 | 123,287 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2014-06-26 | 2014-06-30 | 5,012 | — | $0 | 5,012 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2014-06-13 | 2014-06-16 | 28,000 | $7.96 | $222.9K | 207,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2014-06-12 | 2014-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-06-06 | 2014-06-10 | 202,962 | — | $0 | 202,962 | SEC↗ |
| RESX RestorGenex Corp | C Conversion deriv | 2014-06-06 | 2014-06-10 | 78,473 | — | $0 | 0 | SEC↗ |
| RESX RestorGenex Corp | C Conversion deriv | 2014-06-06 | 2014-06-10 | 76,755 | — | $0 | 0 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-06-06 | 2014-06-10 | 57,566 | — | $0 | 57,566 | SEC↗ |
| RESX RestorGenex Corp | C Conversion deriv | 2014-06-06 | 2014-06-10 | 270,606 | — | $0 | 0 | SEC↗ |
| RESX RestorGenex Corp | C Conversion deriv | 2014-06-06 | 2014-06-10 | 126,894 | — | $0 | 0 | SEC↗ |
| RESX RestorGenex Corp | A Award deriv | 2014-06-06 | 2014-06-10 | 95,170 | — | $0 | 95,170 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-10 | 270,616 | $2.00 | $541.2K | 46,103,949 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-10 | 78,473 | $2.00 | $156.9K | 46,182,422 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-10 | 126,894 | $2.00 | $253.8K | 46,386,071 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-10 | 76,755 | $2.00 | $153.5K | 46,259,177 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-19 | 78,473 | $2.00 | $156.9K | 807,423 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-19 | 76,755 | $2.00 | $153.5K | 884,178 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-19 | 126,894 | $2.00 | $253.8K | 1,011,072 | SEC↗ |
| RESX RestorGenex Corp | C Conversion | 2014-06-06 | 2014-06-19 | 270,616 | $2.00 | $541.2K | 728,950 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2014-05-13 | 2014-05-13 | 45,200 | $2.45 | $110.7K | 250,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2014-05-12 | 2014-05-13 | 60,000 | $6.91 | $414.6K | 179,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2014-05-12 | 2014-05-13 | 4,800 | $2.42 | $11.6K | 204,800 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2014-01-29 | 2014-01-31 | 85,000 | — | $0 | 85,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2014-01-02 | 2014-01-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award | 2014-01-02 | 2014-01-06 | 7,000 | — | $0 | 119,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2013-12-13 | 2013-12-16 | 20,000 | $5.37 | $107.4K | 112,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2013-12-02 | 2013-12-03 | 20,000 | $6.59 | $131.8K | 92,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2013-11-11 | 2013-11-12 | 25,000 | $6.80 | $170.0K | 72,000 | SEC↗ |
| MDGN MEDGENICS, INC. | G Gift deriv | 2013-09-30 | 2013-10-01 | 200,000 | — | $0 | 0 | SEC↗ |
| MDGN MEDGENICS, INC. | G Gift deriv | 2013-09-30 | 2013-10-01 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2013-09-20 | 2013-09-20 | 20,000 | $6.50 | $130.0K | 47,000 | SEC↗ |
| MDGN MEDGENICS, INC. | P Buy | 2013-09-19 | 2013-09-19 | 20,000 | $5.57 | $111.4K | 27,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2013-09-13 | 2013-09-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| NSPR InspireMD, Inc. | G Gift | 2013-07-10 | 2013-07-12 | 850,000 | — | $0 | 850,000 | SEC↗ |
| NSPR InspireMD, Inc. | G Gift | 2013-07-10 | 2013-07-12 | 850,000 | — | $0 | 200,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2013-06-26 | 2013-06-28 | 14,700 | — | $0 | 14,700 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2013-06-13 | 2013-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-05-31 | 2013-05-31 | 20,000 | $2.26 | $45.2K | 1,900,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-05-30 | 2013-05-30 | 20,000 | $2.07 | $41.4K | 1,880,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-05-29 | 2013-05-29 | 20,000 | $2.09 | $41.8K | 1,860,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-05-28 | 2013-05-29 | 20,000 | $2.15 | $43.0K | 1,840,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-05-24 | 2013-05-28 | 20,000 | $2.10 | $42.0K | 1,820,000 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2013-05-10 | 2013-05-13 | 181,250 | — | $0 | 181,250 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2013-05-09 | 2013-05-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-04-25 | 2013-04-26 | 50,000 | $2.00 | $100.0K | 1,800,000 | SEC↗ |
| NSPR InspireMD, Inc. | P Buy | 2013-04-16 | 2013-04-17 | 750,000 | $2.00 | $1.50M | 1,750,000 | SEC↗ |
| NSPR InspireMD, Inc. | A Award deriv | 2013-04-11 | 2013-04-26 | 181,250 | — | $0 | 181,250 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | P Buy | 2013-03-15 | 2013-03-18 | 25,000 | $3.40 | $85.0K | 45,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2013-01-02 | 2013-01-10 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award | 2013-01-02 | 2013-01-10 | 7,000 | — | $0 | 7,000 | SEC↗ |
| NSPR.OB InspireMD, Inc. | P Buy | 2012-11-21 | 2012-11-23 | 34,980 | $1.33 | $46.5K | 4,000,000 | SEC↗ |
| NSPR.OB InspireMD, Inc. | P Buy | 2012-11-20 | 2012-11-21 | 15,020 | $1.29 | $19.4K | 3,965,020 | SEC↗ |
| NSPR.OB InspireMD, Inc. | P Buy | 2012-11-19 | 2012-11-20 | 14,441 | $1.38 | $19.9K | 3,950,000 | SEC↗ |
| NSPR.OB InspireMD, Inc. | P Buy | 2012-11-16 | 2012-11-19 | 35,559 | $1.27 | $45.2K | 3,935,559 | SEC↗ |
| MDGN MEDGENICS, INC. | G Gift deriv | 2012-08-09 | 2013-10-01 | 450,000 | — | $0 | 450,000 | SEC↗ |
| MDGN MEDGENICS, INC. | G Gift deriv | 2012-08-09 | 2013-10-01 | 450,000 | — | $0 | 0 | SEC↗ |
| MDGN MEDGENICS, INC. | A Award deriv | 2012-07-19 | 2012-07-19 | 900,000 | — | $0 | 900,000 | SEC↗ |
| NSPR.OB InspireMD, Inc. | A Award deriv | 2012-06-18 | 2012-06-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FOLD AMICUS THERAPEUTICS INC | A Award deriv | 2012-06-13 | 2012-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AEGR Aegerion Pharmaceuticals, | A Award deriv | 2012-06-05 | 2012-06-07 | 12,854 | — | $0 | 12,854 | SEC↗ |